Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

709
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.4K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

824
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
824
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

7.6K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Centers for Disease Control and Prevention-Harvard T.H. Chan School of Public Health Program Evaluation Practicum.

Journal of public health management and practice : JPHMP·2026
Same author

Worsening versus advanced heart failure: Management and challenges.

ESC heart failure·2025
Same author

COVID-19 pandemic stress and child adjustment: Examining the moderating role of mothers' and fathers' pandemic conversational style.

Developmental psychology·2025
Same author

Editorial Commentary: Spotlight on ATTR cardiomyopathy: the unexpected journey of a once considered "orphan disease".

Trends in cardiovascular medicine·2025
Same author

Evaluating More Granular Options for Socio-Demographic Questions in Autism Research.

Autism research : official journal of the International Society for Autism Research·2025
Same author

Screening for disability-related child maltreatment.

Pediatric research·2025

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Hypertension and ethnicity.

Amanda Bennett1, Parham Parto, Selim R Krim

  • 1aDepartment of Medicine bDivision of Cardiology, John Ochsner Heart and Vascular Center, Ochsner Medical Center cThe University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, Louisiana, USA.

Current Opinion in Cardiology
|May 4, 2016
PubMed
Summary
This summary is machine-generated.

Hypertension control varies by race, with higher awareness and treatment in Black individuals compared to non-Hispanic Whites. Health insurance access is key for Hispanic hypertension management.

More Related Videos

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

23.4K
Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

6.1K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

23.4K
Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

6.1K

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Health Disparities

Background:

  • Hypertension (HTN) prevalence is increasing in minority populations.
  • Limited data exists on HTN control across diverse racial and ethnic groups.
  • Understanding these disparities is crucial for effective public health strategies.

Purpose of the Study:

  • To review recent literature on hypertension epidemiology, prevalence, and treatment.
  • To compare HTN control among non-Hispanic Whites (NHW), Blacks, Hispanics, and Asians.
  • To identify gaps in current knowledge and treatment guidelines.

Main Methods:

  • Systematic review of recent scientific literature.
  • Analysis of epidemiological data on hypertension prevalence.
  • Evaluation of treatment strategies and outcomes across racial groups.

Main Results:

  • Hypertension awareness and treatment are higher in Black individuals than NHWs.
  • Health insurance access significantly impacts HTN control, especially in Hispanic populations.
  • Thiazide diuretics and calcium channel blockers show superior blood pressure lowering in Black individuals compared to other drug classes.

Conclusions:

  • Racial disparities in hypertension awareness and treatment persist.
  • Future research should explore epidemiologic, genetic, and sociologic factors.
  • Tailored therapies are needed to improve HTN management in minority subgroups.